Jaguar Health, Inc. (NASDAQ:JAGX) | Finanzwire

Basculer en Français

10793	Companies
233163	Keywords
161771	Articles
124380	Press releases

Home
Companies
Jaguar Health, Inc.

BRIEF

published on 04/20/2026 at 22:20, 3 months 11 days ago

Jaguar Health Announces Approval of All Proposals at Special Stockholders Meeting

Special Meeting Jaguar Health SEC Filing Stockholders Proposal Approval
PRESS RELEASE

published on 04/20/2026 at 22:15, 3 months 11 days ago

Jaguar Health Reports Approval of All Proposals at April 2026 Special Meeting of Stockholders
Jaguar Health, Inc. announces voting results of Special Meeting of Stockholders with five approved proposals for novel prescription drugs derived from plants for GI and mental health indications

Forward-looking Statements Special Meeting Jaguar Health Stockholders Prescription Drugs
BRIEF

published on 04/13/2026 at 14:35, 3 months 18 days ago

Jaguar Health Explores AI in Crofelemer Development for Intestinal Failure

Jaguar Health AI In Healthcare Crofelemer Development MVID Treatment Intestinal Failure
PRESS RELEASE

published on 04/13/2026 at 14:30, 3 months 18 days ago

Artificial Intelligence (AI) Platforms Could Enhance Jaguar Health's Development and Anticipated Commercialization of Crofelemer for Rare Disease Intestinal Failure (IF) Programs
Jaguar Health plans to utilize AI platforms to enhance the development and commercialization of crofelemer for intestinal failure treatment, targeting ultrarare pediatric disorder MVID

Crofelemer Jaguar Health MVID AI Platforms Intestinal Failure
BRIEF

published on 04/10/2026 at 02:20, 3 months 22 days ago

Jaguar Health Schedules Investor Webcast on Q4 2025 Financials

Financial Updates Forward-looking Statements Investor Webcast Jaguar Health Gastrointestinal Treatments
PRESS RELEASE

published on 04/10/2026 at 02:15, 3 months 22 days ago

Reminder: Jaguar Health to Host Investor Webcast at 8:30 am Eastern on Friday, April 10, 2026 Regarding Q4 2025 Financials and Company Updates
Jaguar Health, Inc. announces participation details for upcoming webcast on April 10, 2026. Learn about their novel prescription drugs derived from plants for GI diseases

Forward-looking Statements Webcast Jaguar Health GI Diseases Prescription Drugs
BRIEF

published on 04/08/2026 at 14:35, 3 months 23 days ago

Jaguar Health Completes Crofelemer Trial for CID in Dogs

Crofelemer FDA Approval Jaguar Health Dog Chemotherapy Diarrhea Treatment
PRESS RELEASE

published on 04/08/2026 at 14:30, 3 months 23 days ago

Jaguar Health Completes Effectiveness Trial to Support FDA Approved Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
Jaguar Health, Inc. completes study on crofelemer for cancer therapy-induced diarrhea in dogs. Results expected to complement positive outcomes. Company plans to file effectiveness study by Q2 2026

Crofelemer Jaguar Health Cancer Therapy Diarrhea Dogs
BRIEF

published on 04/07/2026 at 14:35, 3 months 24 days ago

Jaguar Health Reports Mixed Financial Results for 2025

Jaguar Health Financial Results 2025 Crofelemer Drugs Nasdaq Appeal Future Pak Agreement
PRESS RELEASE

published on 04/07/2026 at 14:30, 3 months 24 days ago

Jaguar Health Reports 2025 Financials
Jaguar Health, Inc. reports a 5% increase in net revenue in Q4 2025 compared to Q3 2025. Company receives $16M upfront payment from Future Pak for license agreement. Financial results include revenue breakdown and operational expenses

Financial Results Jaguar Health License Agreement Q4 2025 Net Revenue Increase

Accesswire

Published on 08/01/2026 at 01:20, 1 day 6 hours ago

Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 1 day 6 hours ago

Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 1 day 7 hours ago

Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 08/01/2026 at 00:25, 1 day 7 hours ago

BioNxt Solutions Announces Option Grants
Published on 07/31/2026 at 23:20, 1 day 8 hours ago

Pentagon I Capital Corp. Announces Conditional Acceptance of Qualifying Transaction with Prospectiva Resources Ltd.

View all ACCESSWIRE

EQS Group

Published on 08/01/2026 at 16:35, 15 hours 19 minutes ago

HIZENERGY Enters Global Top Tier with BloombergNEF Tier 1 Listing
Published on 07/31/2026 at 19:55, 1 day 11 hours ago

EQS-Adhoc: ABO Energy GmbH & Co. KGaA Reaches Agreement with Financing Partners on Extension of Standstill Agreement and Continuation of Restructuring Process
Published on 07/31/2026 at 19:05, 1 day 12 hours ago

Eurobattery Minerals presents the Q2 report for 2026 as the Company accelerates the development of the San Juan tungsten project
Published on 07/31/2026 at 18:55, 1 day 12 hours ago

Holding(s) in Company
Published on 07/31/2026 at 18:53, 1 day 13 hours ago

Deutsche EuroShop SE: Conversion into a European Company Successfully Completed

Les Echos

Published on 07/31/2026 at 21:00, 1 day 10 hours ago

Carrefour completes the sale of its minority stake in CarrefourSA in Turkey to Yeni Mağazacılık A.Ş., operator of the A101 retail chain and controlled by the Aydın Group
Published on 07/31/2026 at 19:27, 1 day 12 hours ago

Share retention commitments (Dutreil Agreement)
Published on 07/31/2026 at 19:14, 1 day 12 hours ago

2026 First-Half financial report
Published on 07/31/2026 at 19:13, 1 day 12 hours ago

Covivio - Information on Treasury shares transactions between July 29th, 2026 and July 31st, 2026
Published on 07/31/2026 at 18:30, 1 day 13 hours ago

Covivio Hotels - 2026 Half-year financial report

View all LES ECHOS COMFI WIRE